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Background:  Questions remain regarding reintervention after percutaneous stent placement for native coarctation of the aorta (CoA). We 
describe our experience.
methods:  All pts with native CoA treated with stent placement between 1997 and 2013 at our institution were included. Records prior to 
intervention and during follow-up were reviewed.
results:  38 pts (32% female) were identified. Median age at intervention: 12.3 yrs (2-51.7 yrs), median weight: 43.7 kg (14.4-92kg). All pts 
had a left aortic arch with juxtaductal CoA. No periprocedural or late mortality occurred. No cases required ICU admission post-intervention. 
Periprocedural complications occurred in 2 pts: 1 stroke and 1 aneurysm at the stent site. Median follow-up: 3.9 yrs (8 days-10.9 yrs). 
12 (%) pts required reintervention at a median of 3.5 yrs (0.9-5.45 yrs) after index procedure. Pts with stents placed before age 12 
accounted for 75% of re-interventions performed to allow for somatic growth. 3 (%) pts less than 12 yrs had unplanned reintervention due 
to aneurysms. Stents with expandable diameter >18 mm were used in 33/38 patients. 3/5 (60%) of pts with smaller stents and 9/33 (27%) 
patients with larger stents required reintervention.
Complete Series, Age 2-51 yrs (n=38)
Pre-intervention Post-intervention p-value
Median SBP gradient at catheterization 33.5 mmHg (8-82) 3.0 mmHg (0-10) <.01
Mean ratio of CoA segment diameter: descending Aorta at diaphragm 0.31 (+/-0.14) 0.88 (+/-0.18) <.01
Presentation Last follow-up visit p-value
Median 4 extremity SBP gradient 38.5 mmHg (2-91) 0.5 mmHg (0-16) <.01
pts hypertensive (SBP >95th percentile) 34/36 (94 %) 10/18 (56%)
Re-intervention during follow-up
<12 years (n=19) >12 years (n=19) p-value
Planned (staged or somatic growth) 8/19 (42%) 1/19 (5 %) <.01
Un-planned 3/19 (16%) 0/19 NS
Total 11/19 (58%) 1/19 (5%)
SBP: systolic blood pressure
Conclusion:  Use of stents expandable to a diameter of >18mm and efforts to achieve a dilated diameter approximate to the descending 
aorta diameter at the diaphragm may limit the frequency of re-interventions in patients treated for native CoA. Planned and un-planned re-
interventions increased under age 12.
